Gonadorelin Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00587431Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer